CGP 3466B maleate
CGP 3466B maleate (Omigapil maleate) is an orally active inhibitor of GAPDH nitrosylation and apoptosis. It has been shown in preclinical studies to reduce Aβ-induced tau pathology and cognitive deficits in mouse models of Alzheimer's disease, and is also investigated for congenital muscular dystrophy research.
Product Specifications
CAS Number
200189-97-5
Product Name Alternative
Omigapil, Omigapil (Maleate), Omigapil Maleate, Omigapil maleate, Apoptosis inhibitor, CGP 3466B Maleate
Field of Research
Cell Biology
Purity
98.58% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.11 mM) ; DMSO:60 mg/mL (153.29 mM)
Smiles
OC (=O) \C=C/C (O) =O.CN (CC#C) CC1=Cc2ccccc2Oc2ccccc12
Molecular Formula
C23H21NO5
Molecular Weight
391.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
R0665h 1 Each
Human CTXI / C-telopeptide of Collagen alpha-1 (I) chain Recombinant Protein
Sign In for Pricing
View Details 
bs-17394R-RBITC 100 µL
HS6ST2 Polyclonal Antibody, RBITC Conjugated
Sign In for Pricing
View Details